| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10157426 | Best Practice & Research Clinical Haematology | 2018 | 20 Pages |
Abstract
Diagnosing double hit lymphoma requires identification of translocations of MYC and BCL2 and/or BCL6. This review will discuss the role of stratification to screen cases based on immunohistochemical profiling as a viable option. Treatment options in the frontline and relapsed setting will be reviewed based on the current literature. Recognition of the risk of CNS involvement and how best to manage this will be discussed. Future considerations and current research will be described.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
BrÃdgÃn Merron, Andrew Davies,